OtoScan - Ear Diagnostic Tools
OtoScan helps to determine the presence or absence of fluid in the middle ear, characterize the type of fluid, visualize the fluid’s density, and can do all of this even in the presence of significant wax.
-
Most popular related searches
Product Details
Impactful Innovation
- 01 Compact, approachable design
- Familiar, handheld device reassures patients
- Adjustable, mobile, all-in-one unit
- Stand-based for easy movement
- Small footprint taking up minimal space in the clinic
- Any healthcare provider can utilize the device with confidence.
- 02 Demonstrable impact on care
- Objective data derived from the middle ear helps to address underlying ear health issues
- Potential to more appropriately prescribe antibiotics
- Can provide objective data to aid in the assessment of hearing loss, chronic ear infections, and resulting learning disabilities
- 03 Two views of the ear
- True color video otoscope view of the ear canal and eardrum
- OtoScan helps to determine the presence or absence of fluid in the middle ear, characterize the type of fluid, visualize the fluid’s density, and can do all of this even in the presence of significant wax
- 04 Taking the guesswork out of ear health
- OtoScan provides an objective assessment of middle ear health.
- OtoSight results are not minimally affected by user or patient variability.
- OtoSight Middle Ear Scope technology is 90.6% accurate when assessing middle ear effusion (fluid)
Details
PhotoniCare Announces Rebranding of First-in-Class Technology for Imaging the Middle Ear, Now called OtoSight Middle Ear Scope
Champaign, IL – PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing healthcare providers with better diagnostic tools, today announced that it is rebranding its middle ear scope to OtoSight™ Middle Ear Scope (formerly TOMi™ Scope). In preparation for the 2021 commercial launch, the OtoSight™ Middle Ear Scope brand name is well-positioned to convey the product’s unique ability to non-invasively see through the eardrum and assess the middle ear space. Using optical coherence tomography (OCT) high resolution depth imaging, OtoSight™ Middle Ear Scope helps to determine the presence or absence of fluid in the middle ear and to characterize the fluid type, even in the presence of significant ear wax.
Data published in January 2020 shows that the technology used in OtoSight Middle Ear Scope is 90.6% accurate in the detection of Middle Ear Effusion.[i] “Current tools can only provide a view of the surface of the eardrum, forcing healthcare providers to make an assessment with very limited information, or to employ invasive surgical procedures to accurately identify middle ear pathologies,” said Diego Preciado, M.D., Ph.D. of the Children’s National Hospital in Washington, D.C., a lead investigator for clinical studies of the device. “OtoSight™ Middle Ear Scope’s advanced light-based technology could dramatically alter the way children with ear problems are evaluated, enhancing our ability to inform optimal treatments.”
Middle ear infections are the leading cause of hearing loss, surgery and antibiotic use, especially in children. Affecting more than 80% of children, they are misdiagnosed up to 50% of the time using the current gold standard, examination via otoscope.[ii] Children can suffer from recurring ear infections for six to 12 months before they are referred to an ENT specialist, and are often prescribed increasingly potent antibiotics during this time. Often, the endpoint of the disease is insertion of tympanostomy tubes in the eardrum. More than one million tube surgeries are performed in the U.S. alone every year.
“Clinicians seeking to be more accurate and confident in their assessment of middle ear fluid and fluid type will find this new technology using light wave detection very helpful,” said Michael Pichichero, M.D., Director of the Rochester General Hospital Research Institute and Research Professor at the Rochester Institute of Technology in New York. “The fact that it works well even in the presence of significant wax build-up is of great value. Wax continues to be a huge problem in middle ear diagnosis.”
PhotoniCare CEO, Ryan Shelton, Wins NWA Pitch CompetitionThe Northwest Arkansas Tech Summit declared Ryan Shelton, CEO and Co-founder of PhotoniCare, as winner of the pitch competition.
The Northwest Arkansas Tech Summit describes itself as “An Event and a Community dedicated to convening thought leaders with diverse perspectives on all things tech”.
PhotoniCare developed the Otosight, a first-in-class, FDA-cleared tool to directly visualize the middle ear without surgery that enables pediatric, family medicine, and urgent care clinicians to immediately and accurately visualize the presence of fluid in the middle ear and characterize that fluid.
Customer reviews
No reviews were found for OtoScan - Ear Diagnostic Tools. Be the first to review!